Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost

Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost

Abstract Background Medications for opioid use disorder (MOUD) significantly decrease mortality but courts rarely refer participants with opioid use disorder to MOUD providers. Previous qualitative work suggests routine court referrals to MOUD providers are more likely if court team members perceive...

Full description

Bibliographic Details
Main Authors: Fatema Z. Ahmed, Barbara Andraka-Christou, M.H. Clark, Rachel Totaram, Danielle N. Atkins, Brandon del Pozo
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Health & Justice
Subjects:
Court
Buprenorphine
Methadone
Naltrexone
Trust
Cost
Online Access:https://doi.org/10.1186/s40352-022-00188-4

Internet

https://doi.org/10.1186/s40352-022-00188-4

Similar Items